Mutations of the JAK2 gene and aberrations of chromosome band 9p24, where JAK2 maps, lead to rearrangements of JAK2 and have been reported in various hematologic neoplasms [9–11]. Here, JAK2 is linked to hematopoietic and lymphoid system neoplasm.